Pulmonary disposition of vancomycin in critically ill patients

被引:61
作者
Georges, H
Leroy, O
Alfandari, S
Guery, B
RousselDelvallez, M
Dhennain, C
Beaucaire, G
机构
[1] UNIV TOURCOING,HOP CHATILLIEZ,BACTERIOL LAB,F-59208 TOURCOING,FRANCE
[2] UNIV LILLE,HOP A CALMETTE,BACTERIOL LAB,SCH MED,LILLE,FRANCE
关键词
D O I
10.1007/BF01726369
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Vancomycin penetration in epithelium lining fluid was studied in ten mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia 24 hours after the onset of treatment. Vancomycin was given intravenously at a daily dose of 30 mg/kg. Vancomycin levels were detectable in four patients (range, 1-2.77 mu g/ml). Concordance between high plasma concentrations (>20 mu g/ml) and detectable vancomycin levels in epithelium lining fluid was noted. These results suggest that the pulmonary disposition of vancomycin remains low for most patients 24 h after the onset of treatment compared with the minimum inhibitory concentrations for most gram-positive organisms. One therapeutic goal of vancomycin treatment could be to obtain through plasma levels of 20 mu g/ml. Further studies are required to determine the clinical relevance of these observations.
引用
收藏
页码:385 / 388
页数:4
相关论文
共 13 条
[1]   PULMONARY DISPOSITION OF ANTIMICROBIAL AGENTS - METHODOLOGICAL CONSIDERATIONS [J].
BALDWIN, DR ;
HONEYBOURNE, D ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1171-1175
[2]   EFFECT OF INTRAVENOUS VANCOMYCIN ON RENAL-FUNCTION [J].
ENG, RHK ;
WYNN, L ;
SMITH, SM ;
TECSONTUMANG, F .
CHEMOTHERAPY, 1989, 35 (05) :320-325
[3]   RETROSPECTIVE STUDY OF THE TOXICITY OF PREPARATIONS OF VANCOMYCIN FROM 1974 TO 1981 [J].
FARBER, BF ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) :138-141
[4]   ANALYSIS OF VANCOMYCIN ENTRY INTO PULMONARY LINING FLUID BY BRONCHOALVEOLAR LAVAGE IN CRITICALLY ILL PATIENTS [J].
LAMER, C ;
DEBECO, V ;
SOLER, P ;
CALVAT, S ;
FAGON, JY ;
DOMBRET, MC ;
FARINOTTI, R ;
CHASTRE, J ;
GIBERT, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :281-286
[5]  
MATZKE GR, 1986, CLIN PHARMACOKINET, V11, P2257
[6]   AN EXPANDED DEFINITION OF THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
MURRAY, JF ;
MATTHAY, MA ;
LUCE, JM ;
FLICK, MR .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (03) :720-723
[7]  
*NAT COMM CLIN LAB, 1993, A7A3 NCCLA
[8]   VENTILATOR-ASSOCIATED PNEUMONIA BY STAPHYLOCOCCUS-AUREUS - COMPARISON OF METHICILLIN-RESISTANT AND METHICILLIN-SENSITIVE EPISODES [J].
RELLO, J ;
TORRES, A ;
RICART, M ;
VALLES, J ;
GONZALEZ, J ;
ARTIGAS, A ;
RODRIGUEZROISIN, R .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) :1545-1549
[9]   ESTIMATION OF VOLUME OF EPITHELIAL LINING FLUID RECOVERED BY LAVAGE USING UREA AS MARKER OF DILUTION [J].
RENNARD, SI ;
BASSET, G ;
LECOSSIER, D ;
ODONNELL, KM ;
PINKSTON, P ;
MARTIN, PG ;
CRYSTAL, RG .
JOURNAL OF APPLIED PHYSIOLOGY, 1986, 60 (02) :532-538
[10]   PHARMACOKINETICS OF VANCOMYCIN - OBSERVATIONS IN 28 PATIENTS AND DOSAGE RECOMMENDATIONS [J].
ROTSCHAFER, JC ;
CROSSLEY, K ;
ZASKE, DE ;
MEAD, K ;
SAWCHUK, RJ ;
SOLEM, LD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (03) :391-394